Improved identification of patients 'at risk' of depression, and optimal targeting of rehabilitation post-stroke through novel brain imaging and biomarkers.

通过新型脑成像和生物标志物，更好地识别“有抑郁症风险”的患者，并优化中风后康复的目标。

• 批准号: FT0992299
• 负责人: Prof Leeanne Carey
• 金额: $ 48.96万
• 依托单位: National Stroke Research Institute
• 依托单位国家: 澳大利亚
• 项目类别: ARC Future Fellowships
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/FT0992299
• 关键词: Improved; identification; patients; risk; depression

Use of novel brain imaging and biomarkers for identification of stroke survivors at risk of depression and recurrent stroke will permit early access to preventative and effective treatments for depression and improve capacity to benefit from rehabilitation. Development of predictive models to guide selection of most optimal rehabilitation strategies based on viable brain will maximise the capacity for persons with stroke to reach their full potential for recovery and ensure rehabilitation is more targeted and cost efficient. Improved capacity to benefit from treatment will have ongoing benefits for activity participation and productive living in Australians who experience stroke.

使用新的脑成像和生物标志物来识别有抑郁风险和复发中风的中风幸存者，将使人们能够及早获得预防和有效的抑郁症治疗，并提高从康复中受益的能力。开发预测模型以指导基于可存活大脑的最佳康复策略的选择，将最大限度地提高中风患者充分发挥康复潜力的能力，并确保康复更具针对性和成本效益。提高从治疗中受益的能力将对经历中风的澳大利亚人的活动参与和富有成效的生活产生持续的好处。